One-Stop In Vitro Diagnostics (IVD) CDMO Partner | From Lab to Market
Expert Call: (86) 23-86916205

IVD Industry Insights

China’s Silicon Valley of Medical Hardware: Decoding Shenzhen’s International Stature in IVD CDMO Industrial Evolution

The Tectonic Shift Reshaping the Global IVD Industry The global in vitro diagnostics (IVD) sector is undergoing a fundamental structural reshuffle, driven by overlapping macro and industrial forces. Worldwide healthcare systems are tightening medical reimbursement standards alongside DRG-based hospital cost containment frameworks, while China’s volume-based procurement (VBP) policy continues to compress gross profit margins for conventional diagnostic products. Concurrently, the industry is wi...
Read More

Next-Generation Sequencing (NGS) Technology Roadmap: A Definitive Deep Dive

Over the past two decades, Next-Generation Sequencing (NGS) has evolved from lab-scale proof-of-concept technology into the foundational infrastructure underpinning contemporary genomics, catalyzing transformative shifts across precision oncology, companion diagnostic development, reproductive genetic testing and synthetic biology R&D. This peer-grade review partitions NGS’s industrial evolution into four defined developmental eras: foundational commercial emergence (2005–2010), mainstre...
Read More

Global IVD CDMO Industry: 2026 Development Trends, Competitive Landscape and Long-Term Market Outlook

The global in vitro diagnostics contract development and manufacturing organization (IVD CDMO) industry has evolved into an indispensable outsourcing backbone of the modern diagnostic healthcare ecosystem. Driven by the rapid iteration of diagnostic technologies toward molecular precision, decentralized testing, and intelligent automation, IVD manufacturers, biotech startups, and pharmaceutical enterprises are increasingly adopting asset-light strategies, outsourcing core development, manufactur...
Read More